Otis Worldwide Operating Cash Flow decreased by 49.4% to $413.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 117.4%, from $190.00M to $413.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a -2.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $533.00M | $355.00M | $277.00M | $504.00M | $353.00M | $239.00M | $464.00M | $278.00M | $446.00M | $306.00M | $597.00M | $171.00M | $308.00M | $394.00M | $690.00M | $190.00M | $215.00M | $374.00M | $817.00M | $413.00M |
| QoQ Change | — | -33.4% | -22.0% | +81.9% | -30.0% | -32.3% | +94.1% | -40.1% | +60.4% | -31.4% | +95.1% | -71.4% | +80.1% | +27.9% | +75.1% | -72.5% | +13.2% | +74.0% | +118.4% | -49.4% |
| YoY Change | — | — | — | — | -33.8% | -32.7% | +67.5% | -44.8% | +26.3% | +28.0% | +28.7% | -38.5% | -30.9% | +28.8% | +15.6% | +11.1% | -30.2% | -5.1% | +18.4% | +117.4% |